DETAILS OF ETHICS APPROVAL:
The
primary study was approved by the institutional review board at each
clinical site and the data coordinating center. The secondary analysis
was approved by the University of Pittsburgh Institutional Review Board
(no. 13110579). Initial approval date: 2 February 2014. Final approval
date: 6 November 2019.